Home » MUREX PHARMACEUTICALS ANNOUNCES JOINT DEVELOPMENT AGREEMENT WITH GENE NETWORK SCIENCES
MUREX PHARMACEUTICALS ANNOUNCES JOINT DEVELOPMENT AGREEMENT WITH GENE NETWORK SCIENCES
Murex Pharmaceuticals today announced its joint agreement with Gene Network Sciences (GNS) to develop cancer therapeutics. Murex, a Dallas-based pharmaceutical company, will utilize technology from GNS to create computer-based models that enhance identification and validation of cancer targets.
PipelioneReview.com
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May